Pfizer ends sale of hormone therapy cream Premarin in Canada

Pfizer has discontinued the sale of its hormone replacement therapy Premarin in Canada after a company review. This therapy, available in both cream and tablet forms, has been used for menopausal symptoms. The decision could impact thousands of Canadian women who relied on Premarin for relief from symptoms like hot flashes and vaginal dryness. This move highlights broader concerns about hormone therapy's long-term health effects and underscores the importance of ongoing research in this area.